MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells

Title
MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 11, Issue 1, Pages 174-182
Publisher
American Association for Cancer Research (AACR)
Online
2011-11-16
DOI
10.1158/1535-7163.mct-11-0529

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started